Inspire Advisors’s Dare Bioscience DARE Stock Holding History

Inspire Advisors’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-39	Closed	-$1K	–	238
2020 Q4	$1K	Buy	+39	New	+$546	﹤0.01%	730

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

Inspire Advisors's DARE Position: Q1 2021 in Review

Inspire Advisors sold out of Dare Bioscience (DARE) in Q1 2021, closing a stake of 39 shares — an estimated $1K sold.

Inspire Advisors first reported a position in DARE in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 30 funds tracked by Wall St. Rank hold DARE as of Q1 2021.

Inspire Advisors reported no remaining Dare Bioscience position as of Q1 2021 after selling out during the quarter.
Inspire Advisors sold 39 Dare Bioscience shares in Q1 2021, an estimated $1K.
Inspire Advisors first reported a position in Dare Bioscience in Q4 2020 and held it in 1 quarter.
Inspire Advisors's Dare Bioscience position peaked at $1K in Q4 2020.
30 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.